Aclaris Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	18.72	31.25	29.5	6.64	6.48	Upgrade
Other Revenue	-	-	0.26	0.12	0.01	Upgrade
Revenue	18.72	31.25	29.75	6.76	6.48	Upgrade
Revenue Growth (YoY)	-40.09%	5.03%	340.05%	4.30%	53.35%	Upgrade
Cost of Revenue	49.04	114.25	89.77	48.53	34.47	Upgrade
Gross Profit	-30.32	-83	-60.02	-41.77	-27.99	Upgrade
Selling, General & Admin	22.2	31.51	25.13	23.62	20.53	Upgrade
Operating Expenses	22.2	31.51	25.13	23.62	20.53	Upgrade
Operating Income	-52.53	-114.51	-85.15	-65.38	-48.52	Upgrade
Interest & Investment Income	7.95	8.51	-	-	-	Upgrade
Other Non Operating Income (Expenses)	1.91	-	2.95	-1.14	-0.42	Upgrade
EBT Excluding Unusual Items	-42.66	-106	-82.21	-66.53	-48.94	Upgrade
Merger & Restructuring Charges	-	-3.12	-	-	-	Upgrade
Other Unusual Items	-2.5	26.9	-4.7	-24.34	-2.39	Upgrade
Pretax Income	-132.07	-88.85	-86.91	-90.87	-51.34	Upgrade
Income Tax Expense	-	-0.37	-	-	-0.18	Upgrade
Earnings From Continuing Operations	-132.07	-88.48	-86.91	-90.87	-51.15	Upgrade
Earnings From Discontinued Operations	-	-	-	-	0.14	Upgrade
Net Income	-132.07	-88.48	-86.91	-90.87	-51.02	Upgrade
Net Income to Common	-132.07	-88.48	-86.91	-90.87	-51.02	Upgrade
Shares Outstanding (Basic)	77	70	65	57	43	Upgrade
Shares Outstanding (Diluted)	77	70	65	57	43	Upgrade
Shares Change (YoY)	10.73%	7.05%	14.95%	33.36%	2.94%	Upgrade
EPS (Basic)	-1.71	-1.27	-1.33	-1.60	-1.20	Upgrade
EPS (Diluted)	-1.71	-1.27	-1.33	-1.60	-1.20	Upgrade
Free Cash Flow	-20.2	-79.63	-68.17	-52.44	-39.09	Upgrade
Free Cash Flow Per Share	-0.26	-1.14	-1.04	-0.92	-0.92	Upgrade
Gross Margin	-161.99%	-265.60%	-201.74%	-	-	Upgrade
Operating Margin	-280.59%	-366.44%	-286.21%	-967.08%	-748.52%	Upgrade
Profit Margin	-705.48%	-283.15%	-292.11%	-1343.96%	-787.03%	Upgrade
Free Cash Flow Margin	-107.89%	-254.84%	-229.13%	-775.65%	-602.99%	Upgrade
EBITDA	-52.22	-114.45	-	-65.06	-48.2	Upgrade
EBITDA Margin	-278.95%	-	-	-	-	Upgrade
D&A For EBITDA	0.31	0.06	-	0.32	0.32	Upgrade
EBIT	-52.53	-114.51	-85.15	-65.38	-48.52	Upgrade
EBIT Margin	-280.59%	-	-286.21%	-	-	Upgrade
Revenue as Reported	18.72	31.25	29.75	6.76	6.48	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q